Evaluation of TAOK2 as a novel therapeutic target for personalized treatment of triple negative and HER2 breast cancers

Project: Research

Project Description

NBCF application
StatusNot started
Effective start/end date1/11/1930/10/21

Funding

  • National Breast Cancer Foundation: AUD479,326.00